Cardiac Surgeon's Primer: Tissue-Engineered Cardiac Valves

Pediatric Cardiac Surgery Annual

Volumn 10, Issue 1, 2007, Pages 125-135

  Hopkins, Richard ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

aortic valve; cardiac valves; Tissue engineering

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOMATERIAL; BLOOD CLOTTING FACTOR 8; CHONDROITIN SULFATE; COLLAGEN; DECORIN; DESMIN; ELASTIN; FIBRONECTIN; HEAT SHOCK PROTEIN 47; NITRIC OXIDE SYNTHASE; SMOOTHELIN; VIMENTIN;

ARTICLE; BIODEGRADABILITY; BIOMECHANICS; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL TRIAL; EQUIPMENT DESIGN; EXTRACELLULAR MATRIX; FOOD AND DRUG ADMINISTRATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEART VALVE SURGERY; HUMAN; MYOFIBROBLAST; NONHUMAN; PATIENT SAFETY; PEDIATRIC SURGERY; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; STEM CELL; TISSUE ENGINEERING; VALVULAR HEART DISEASE; ANIMAL; CYTOLOGY; HEART VALVE; REVIEW; SAFETY; STANDARD; UNITED STATES;

ANIMALS; DEVICE APPROVAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; TISSUE ENGINEERING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34147108158     PISSN: 10929126     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.pcsu.2007.01.004     Document Type: Article

References (63)

1. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
2. Nerem R.M. Introduction. In: Lanza J., Langer R., and Vacante J. (Eds). Principles of Tissue Engineering (2000), Springer-Verlag, New York, NY 1-10
3. MacArthur B.D., and Oreffo R.O.C. Bridging the gap. Nature 433 (2005) 19-27
4. Hilbert S.L., Yanagida R., Souza J., et al. Prototype anionic detergent technique used to decellularized allograft valve conduits evaluated in the right ventricular outflow tract in sheep. J Heart Valve Dis 13 (2004) 831-840
5. Hopkins R.A. Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds. [invited editorial]. Circulation 111 (2005) 2712-2714
6. Breuer C.K., Mettler B.A., Anthony T., et al. Application of tissue engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng 10 (2004) 1725-1736
7. Long J.T., and Tranquillo R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 22 (2003) 339-350
8. Hoffman-Kim D., Maish M.S., Krueger P.M., et al. Comparison of three myofibroblast cell sources for tissue engineering cardiac valves. Tissue Eng 11 (2005) 1-12
9. Messier Jr. R., Bass B., Aly H., et al. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: Characteristics of the leaflet myofibroblast. J Surg Res 57 (1994) 1-21
10. Roy A., Brand N.J., and Yacoub M.H. Molecular characterization of interstitial cells isolated from human heart valves. J Heart Valve Dis 9 (2000) 459-464
11. Schenke-Layladm K., Riemann I., Optiz F., et al. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biology 23 (2004) 113-125
12. Hilbert S.L., Luna R.E., Zhang J., et al. Allograft heart valves: The role of apoptosis-mediated cell loss. J Thorac Cardiovasc Surg 117 (1999) 454-462
13. Messier Jr. R., Domkowski P., Aly H., et al. Adenine nucleotide depletion in cryopreserved human cardiac valves: The 'stunned' leaflet interstitial cell population. Cryopreserved Biol 32 (1995) 199-208
14. Hopkins R.A. From cadaver derived homograft valves to tissue engineered valve conduits. Prog Pediatr Cardiol 21 (2006) 137-151
15. Magid R., Murphy T.J., and Galis Z.S. Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of C-Myc. J Biol Chem 29 (2003) 32994-32999
16. Hopkins R.A. The new age of cardiac surgery driven by tissue engineering and biotechnology. Med Health R I 89 (2006) 6-9
17. Merryman W.D., Youn H.D., Lukoff H., et al. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: Implications for collagen biosynthesis. I. Am J Physiol Heart Circ Physiol 290 (2006) 224-231
18. Brown J.W., Ruzmetov M., Palaniswamy V., et al. The Ross-Konno procedure in children: Outcomes, autograft and allograft function, and reoperations. Ann Thorac Surg 82 (2006) 1301-1307
19. Bove E.L., Kavey R.E., Byrum C.J., et al. Improved right ventricular function following late pulmonary valve replacement for residual pulmonary insufficiency or stenosis. J Thorac Cardiovasc Surg 90 (1985) 50-55
20. Therrien J., Provost Y., Merchant N., et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 95 (2005) 779-782
21. Piatosa B., Birbach M., Fedorowicz M., et al. Presence of IgG anti-HLA antibodies in fourteen patients after cryopreserved allogenic heart valve implantation. Transplant Proc 34 (2002) 643-644
22. Rieder E., Seebacher G., Kasimir M.T., et al. Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111 (2005) 2792-2797
23. Christenson J.T., Vala D., Sierra J., et al. Blood group incompatibility and accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg 127 (2004) 242-250
24. Clarke D.R., Campbell D.N., Hatward A.R., et al. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 105 (1993) 934-941
25. Rajani B., Mee R.B., and Ratliff N.B. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg 115 (1998) 111-117
26. Shaddy R.E., Hunter D.D., and Osborn K.A. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts in pediatric cardiac surgery: Comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg 126 (2003) 247-252
27. Baskett R.J., Nanton M.A., Warren A.E., et al. Human leukocyte antigen-DR and ABO mismatch associated with accelerated homograft valve failure in children: Implications for therapeutic interventions. J Thorac Cardiovasc Surg 126 (2003) 232-239
28. Wells W.J., Arroyo J., Bremner R.M., et al. Homograft conduit failure in infants is not due to somatic outgrowth. J Thorac Cardiovasc Surg 124 (2002) 88-96
29. Tweddell J.S., Pelech A.N., and Frommelt P.C. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 102 (2000) 130-135
30. Dearani J.A., Danielson G.K., and Pega F.J. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 75 (2003) 399-411
31. Hawkins J.A., Bailey W.W., Dillon T., et al. Midterm results with cryopreserved allografts valved conduits from the right ventricle to the pulmonary arteries. J Thorac Cardiovasc Surg 104 (1992) 910-916
32. Koolbergen D.R., Hazekamp M.G., de Heer E., et al. The pathology of fresh and cryopreserved heart valves: An analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg 124 (2002) 689-697
33. Hoerstrup S.P., Kadner A., and Breymann C. Living autologous pulmonary artery conduit tissue engineered from human umbilical cord cells. Ann Thorac Surg 74 (2002) 46-52
34. Boh J.O., Botha C.A., Horke A., et al. Is the Ross operation still an acceptable option in children and adolescents?. Ann Thorac Surg 82 (2006) 940-947
35. Simon P., Kasimir M.T., Seebacher G., et al. Early failure of the tissue engineered porcine heart valve synergraft in pediatric patients. Eur J Cardiothorac Surg 23 (2003) 1002-1006
36. ISO 5840: Cardiovascular Implants. Ed 4. (2005), International Organization for Standardization, Switzerland
37. Zehr K.J., Yagubyan M., Connolly H.M., et al. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: Postoperative immunoreactivity and early results. J Thorac Cardiovasc Surg 130 (2005) 1010-1015
38. Hopkins R.A. Cardiac Reconstructions with Allograft Tissues (2005), Springer-Verlag, New York, NY
39. Ketchedjian A., Krueger P., Lukoff H., et al. Ovine panel reactive antibody assay of HLA response to allograft bioengineered vascular scaffolds. J Thorac Cardiovasc Surg 129 (2005) 159-166
40. Gallegos R.P., Nockel P.J., Rivard A.L., et al. The current state of in vivo pre-clinical animal models for heart valve evaluation. J Heart Valve Dis 14 (2005) 423-432
41. Schoen F.J., and Levy R.J. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mat Res 47 (1999) 439-465
42. Shinoka T., Ma P.X., Shum-Tim D., et al. Tissue-engineered heart valves: Autologous valve leaflet replacement study in a lamb model. Circulation 94 (1996) II-164-II-168
43. Shinoka T., Shum-Tim D., Ma P.X., et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115 (1998) 536-546
44. Elkins R.C., Dawson P.E., Goldstein S., et al. Decellularized human valve allografts. Ann Thorac Surg 71 (2001) S428-S432
45. Booth C., Korossis S.A., and Wilcox H.E. Tissue engineering of cardiac valve prostheses. I: Development and histologic characterization of an acellular scaffold. J Heart Valve Dis 11 (2002) 457-462
46. Breuer C.K., Mettler B.A., Anthony T., et al. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng 10 (2004) 1725-1736
47. Hilbert S.L., Sword L.C., Batachelder K.C., et al. The simultaneous assessment of bioprosthetic heart valve biomechanical properties and collagen crimp length. J Biomed Mat Res 31 (1996) 503-509
48. Rhim C., and Niklason L.E. Tissue engineered vessels: Cells to telomeres. Progr Pediatr Cardiol 21 (2006) 185-191
49. Fong P., Shin'oka T., Lopez-Soler R.I., et al. The use of polymer based scaffolds in tissue-engineered heart valves. Progr Pediatr Cardiol 21 (2006) 193-199
50. Taylor P.M., Cass A.E.G., and Yacoub M.H. Extracellular matrix scaffolds for tissue engineering heart valves. Progr Pediatr Cardiol 21 (2006) 219-225
51. Simon P., Kasimir M.T., Rieder E., et al. Tissue engineering of heart valves: immunologic and inflammatory challenges of the allograft scaffold. Progr Pediatr Cardiol 21 (2006) 161-165
52. Johnson T.L., Barabino G.A., and Nerem R.M. Engineering more physiologic in-vitro models for the study of vascular biology. Progr Pediatr Cardiol 21 (2006) 201-210
53. Flanagan T.C., and Pandit A. Living artificial heart valve alternatives: A review. Eur Cell Mater 6 (2003) 28-76
54. Hawkins J.A., Hillman N.D., Lambert L.M., et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: Comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg 126 (2003) 247-252
55. Flameng W., Meuris B., Yperman J., et al. Factors influencing calcification of cardiac bioprostheses in adolescent sheep. J Thorac Cardiovasc Surg 132 (2006) 89-98
56. Jones M., Eidbo E.E., Hilbert S.L., et al. The effects of anticalcification treatments on bioprosthetic heart valves implanted in sheep. ASAIO Trans 34 (1988) 1027-1030
57. Schoen F.J., Levy R.J., Nelson A.C., et al. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 52 (1985) 523-532
58. Flameng W.J., Ozaki S., Yperman J., et al. Calcification characteristics of porcine stented valves in a juvenile sheep model. Ann Thorac Surg 71 (2001) S401-S405
59. Abolhoda A., Oyarzun J.R., McCormick J.R., et al. Calcification of bovine pericardium: gluteraldehyde versus no-react biomodification. Ann Thorac Surg 62 (1996) 169-174
60. Kasimir M.T., Tieder E., Seebacher G., et al. Presence and elimination of the xenoantigen Gal (α1, 3) Gal in tissue engineered heart valves. Tissue Eng 11 (2005) 1180-1274
61. Chern E., Sapirstein W., Ahn C., et al. FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg 82 (2006) 773-775
62. Grunkmeier G.L., Jin R., and Starr A. Prosthetic heart valves: Objective performance criteria versus randomized clinical trial. Ann Thorac Surg 82 (2006) 776-780
63. Parides M.K., Mokowitz A.J., Ascheim D.D., et al. Progress versus precision: Challenges in clinical trial design for left ventricular assist devices. Ann Thorac Surg 82 (2006) 1140-1146